7Baggers
 published on: 2025-11-16 06:02:52  newser.com Sun, 16 Nov 2025 12:02:52 GMT
 (BEAM) Risk Channels and Responsive Allocation  news.stocktradersdaily.com Sat, 15 Nov 2025 23:36:01 GMT
 Beam Therapeutics prices $500M offering  MSN Tue, 11 Nov 2025 07:52:57 GMT
 Beam Therapeutics Bets Big On Precision Gene Editing  Finimize Sun, 09 Nov 2025 13:51:03 GMT
 Beam Therapeutics Stock (BEAM) Opinions on Clinical Trial Updates  Quiver Quantitative Sun, 09 Nov 2025 08:00:00 GMT
 beam therapeutics to participate in upcoming september 2025 investor conferences  Markets Financial Content Sun, 09 Nov 2025 06:36:00 GMT
 Beam Therapeutics achieves top CGT award for BEAM-302  Traders Union Thu, 06 Nov 2025 17:30:34 GMT
 bofa securities maintains beam therapeutics(beam.us) with buy rating  富途牛牛 Wed, 05 Nov 2025 16:33:00 GMT
 Beam Therapeutics (BEAM) Q3 Earnings Miss Estimates  GuruFocus Wed, 05 Nov 2025 09:45:00 GMT
 decoding beam therapeutics inc (beam): a strategic swot insight  GuruFocus Wed, 05 Nov 2025 05:37:56 GMT
 beam therapeutics reports q3 2025 financial results  TipRanks Wed, 05 Nov 2025 04:51:20 GMT
 ARK Investment Acquires Significant Stake in Beam Therapeutics (  GuruFocus Wed, 05 Nov 2025 02:58:56 GMT
 (beam) movement as an input in quant signal sets  news.stocktradersdaily.com Tue, 04 Nov 2025 22:20:02 GMT
 beam (beam) advances clinical programs in genetic disease base e  GuruFocus Tue, 04 Nov 2025 13:07:19 GMT
 beam therapeutics reports q3 eps ($1.10), consensus ($1.03)  TipRanks Tue, 04 Nov 2025 12:38:21 GMT
 Beam Therapeutics Inc. SEC 10-Q Report  TradingView Tue, 04 Nov 2025 12:13:00 GMT
 william blair maintains beam therapeutics(beam.us) with buy rating  富途牛牛 Tue, 04 Nov 2025 10:32:00 GMT
 Beam Therapeutics Reports Q3 2025 Financial Results  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 beam therapeutics stock faces pivotal week with key catalysts ahead  AD HOC NEWS Tue, 04 Nov 2025 02:00:04 GMT
 ARK Investment Acquires Significant Stake in Beam Therapeutics (  GuruFocus Tue, 04 Nov 2025 01:39:02 GMT
 Beam Therapeutics to Present Updated Data from BEACON Phase  GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT
 published on: 2025-11-02 01:58:11  newser.com Sun, 02 Nov 2025 06:58:11 GMT
 5 best etfs tracking crispr gene editing  The Motley Fool Sat, 01 Nov 2025 02:52:00 GMT
 published on: 2025-10-31 03:50:40  newser.com Fri, 31 Oct 2025 08:50:40 GMT
 fmr llc sells 459 shares of beam therapeutics (nasdaq:beam) stock  MarketBeat Thu, 30 Oct 2025 20:33:54 GMT
 fmr llc makes a strategic move with beam therapeutics stock!  TipRanks Thu, 30 Oct 2025 02:38:54 GMT

Beam Therapeutics Inc
(NASDAQ:BEAM) 

BEAM stock logo

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease...

Founded: 2017
Full Time Employees: 166
CEO: John Evans  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends